Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa

Tuberculosis is a global threat to which infants are especially vulnerable. Effective vaccines are required to protect infants from this devastating disease. VPM1002, a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine previously shown to be safe and immunogenic in adults,...

Descripción completa

Detalles Bibliográficos
Autores principales: Loxton, André G., Knaul, Julia K., Grode, Leander, Gutschmidt, Andrea, Meller, Christiane, Eisele, Bernd, Johnstone, Hilary, van der Spuy, Gian, Maertzdorf, Jeroen, Kaufmann, Stefan H. E., Hesseling, Anneke C., Walzl, Gerhard, Cotton, Mark F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/
https://www.ncbi.nlm.nih.gov/pubmed/27974398
http://dx.doi.org/10.1128/CVI.00439-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299117/
https://www.ncbi.nlm.nih.gov/pubmed/27974398
http://dx.doi.org/10.1128/CVI.00439-16

Ejemplares similares